Cancer research
Researchers at Shanghai Jiao Tong University have discovered that circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in peritoneal lavage fluid can predict peritoneal metastasis of gastric cancer. The study, published in Translational Research, found that patients with stage III gastric cancer who tested positive for ctDNA and CTCs
Cancer
Gastric cancer remains one of the most common and deadly cancer types worldwide. Researchers from the Federal University of Sao Paulo have identified two minimally invasive biomarkers in peripheral blood that can be used for gastric cancer detection and postoperative monitoring. The study, published in In Vivo, found that expression
Cancer
New research from the Department of Oncology at the Affiliated Hospital of Soochow University in Changzhou, People's Republic of China, has shed light on the role of mitochondrial-related nuclear genes (MNGs) in gastric cancer (GC). By analyzing GC-related transcriptome data from the gene expression omnibus and cancer genome
Cancer
Researchers have made significant progress in understanding the role of circulating tumor DNA (ctDNA) methylation in gastric cancer, a disease characterized by great tumor heterogeneity and genetic differences among subgroups. According to a recent study published in the World Journal of Gastrointestinal Oncology, ctDNA methylation has been linked to early
Cancer
Researchers at Universidad Cientifica del Sur have made a breakthrough in gastric cancer treatment by discovering a potential therapeutic agent in the chloroform fraction of Dracontium spruceanum bulb. This natural compound, further referred to as DSBCl, has shown remarkable efficacy in modulating cancer stem cells (CSCs) and inhibiting tumor growth.
Cancer
A study published in the Turkish Journal of Surgery investigated the relationship between muscular atrophy, sarcopenia, and postoperative outcomes in patients with gastric cancer. Researchers from Marmara University found that patients with sarcopenia and myosteatosis, a condition characterized by low muscle density, had poorer surgical outcomes and shorter overall survival
Cancer research
Research conducted at the University Medical Center in Ho Chi Minh City, Vietnam, has identified a promising approach for treating gastric cancer with bulky lymph nodes. The study, which involved 32 patients, evaluated the efficacy of a modified regimen of preoperative chemotherapy using docetaxel, cisplatin, and S-1 (DCS). The results
Cancer research
Researchers at Erasmus University Medical Center Cancer Institute have made a breakthrough in the treatment of gastric cancer, reporting promising results from a phase I trial of intraperitoneal irinotecan with systemic capecitabine and oxaliplatin. The trial, which involved patients with gastric cancer and peritoneal metastases, demonstrated a median overall survival
Cancer research
A recent study published in the Journal of Oncological Sciences has provided new insights into the effectiveness of various chemotherapy regimens for treating metastatic gastric cancer. The research, conducted by a team of scientists at Ege University Faculty of Medicine, aimed to evaluate the impact of triplet versus doublet chemotherapy
Cancer research
Research conducted by investigators at Tel Aviv University has shed light on the implications of early reoperations after gastrectomy for gastric adenocarcinoma patients. Gastrectomy, a central component of curative treatment for gastric cancer, is associated with significant postoperative risks, including severe complications. However, the impact of early reoperations on long-term
Cancer research
Research conducted by the Sakai City Medical Center has provided new insights into the effectiveness of radiotherapy (RT) and transarterial embolization (TAE) in treating advanced gastric cancer bleeding. The study, published in the journal BMC Gastroenterology, analyzed patients with advanced gastric cancer who experienced uncontrollable bleeding and were treated with
Cancer research
Researchers at I-Shou University in Taiwan have identified a potential therapeutic agent for treating gastric cancer. According to a new report, linolenic acid, a type of omega-3 fatty acid, has shown promising results in targeting cancer stemness and inducing apoptosis in gastric cancer cells. The study, published in Current Issues
